BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18050580)

  • 1. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
    Shetty K
    Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thalidomide comeback.
    HIV Hotline; 1998 May; 8(2):7, 9, 15. PubMed ID: 11365364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide's comeback.
    Vazquez E
    Posit Aware; 1998; 9(4):53-4. PubMed ID: 11365634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide: a re-look.
    Grover JK; Vats V; Gopalakrishna R; Ramam M
    Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and HIV: several possible uses.
    Smith D
    AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New uses of thalidomide.
    Med Lett Drugs Ther; 1996 Feb; 38(968):15-6. PubMed ID: 8592478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
    Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
    J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
    Shetty K
    Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide: 40 years on.
    Diggle GE
    Int J Clin Pract; 2001 Nov; 55(9):627-31. PubMed ID: 11770361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphthous stomatitis and its management.
    Santis HR
    Curr Opin Dent; 1991 Dec; 1(6):763-8. PubMed ID: 1807480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomid: current role in the treatment of non-plasma cell malignancies.
    Kumar S; Witzig TE; Rajkumar SV
    J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores).
    Manesis DA
    STEP Perspect; 1995; 7(1):16-7. PubMed ID: 11362397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of thalidomide in HIV infection.
    Taiwo BO
    AIDS Read; 2001 Oct; 11(10):511-3, 518-9, 523-4. PubMed ID: 11708084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide for wasting syndrome: progress toward compromise.
    James JS
    AIDS Treat News; 1995 Nov; (no 234):1-5. PubMed ID: 11363041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.